comtripsy 20 tablet

Comtripsy 20 Tablet – Product Description Comtripsy 20 Tablet is a prescription anticancer medicine containing Trifluridine 20 mg + Tipiracil. It is used under the supervision of an oncologist for certain advanced or metastatic cancers, particularly colorectal cancer and, in appropriate patients, advanced gastric or gastro-oesophageal junction cancer. Key Benefits Used in the treatment of certain advanced/metastatic cancers. Helps slow the growth and multiplication of cancer cells. Trifluridine interferes with cancer-cell DNA synthesis. Tipiracil helps maintain trifluridine levels in the body by reducing its breakdown. Composition Trifluridine 20 mg + Tipiracil Note: published pharmacy listings differ on the exact tipiracil amount for the Comtripsy 20 formulation, so the strength printed on the medicine pack should be verified before publishing a product listing. Common Side Effects Possible side effects include anemia, reduced white blood cell/neutrophil counts, low platelet count, fatigue, nausea, vomiting, diarrhea, decreased appetite and fever. Important Safety Information Comtripsy 20 should be taken only as prescribed by an oncologist. Regular blood-count monitoring may be required because treatment can reduce blood-cell counts and increase the risk of infection. Seek medical attention promptly for fever or signs of infection. Disclaimer: This content is for general product information and does not replace medical advice. Comtripsy 20 is a prescription anticancer medicine and should be used strictly according to your doctor's instructions.